Adherence to antiretroviral therapy for pediatric HIV infection: A qualitative systematic review with recommendations for research and clinical management

Pediatrics

Volumn 119, Issue 6, 2007, Pages

  Simoni, Jane M ^a   Montgomery, Arianna ^b   Martin, Erin ^c   New, Michelle ^c   Demas, Penelope A ^d   Rana, Sohail ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d MONTEFIORE MEDICAL CENTER   (United States)

^e HOWARD UNIVERSITY   (United States)

Author keywords

Adherence; Compliance; HIV AIDS; Interventions; Pediatric

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; NELFINAVIR;

ALCOHOL CONSUMPTION; CAREGIVER; CHILD BEHAVIOR; CHILD PARENT RELATION; CHILDHOOD DISEASE; CLINICAL RESEARCH; DEPRESSION; DOSAGE SCHEDULE COMPARISON; DRUG COST; DRUG EFFICACY; FAMILY; FEASIBILITY STUDY; FOSTER CARE; GROUPS BY AGE; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOUSING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUALITY OF LIFE; RACE DIFFERENCE; REVIEW; SOCIAL SUPPORT; STRESS; SYSTEMATIC REVIEW;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; DISEASE MANAGEMENT; HEALTH PLANNING GUIDELINES; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; PRACTICE GUIDELINES;

EID: 34249888233     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-1232     Document Type: Review

References (87)

1. Haynes RB. Compliance in Health Care. Baltimore, MD: Johns Hopkins University; 1979
2. Besch CL. Compliance in clinical trials. AIDS. 1995;9:1-10
3. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications [published correction appears in Lancet. 1997;349:1180]. Lancet. 1996;348:383-386
4. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique [published correction appears in JAMA. 1989;262:1472]. JAMA. 1989;261:3273-3277
5. De Geest S, Borgermans L, Gemoets H, et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation. 1995;59:340-347
6. de Klerk E, van der Linden SJ. Compliance monitoring of NSAID drug therapy in ankylosing spondylitis, experiences with an electronic monitoring device. Br J Rheumatol. 1996;35:60-65
7. Task Force for Noncompliance. Noncompliance With Medications: An Economic Tragedy With Important Implications for Health Care Reform. Baltimore, MD: National Pharmaceutical Council; 1994
8. Feingold AR, Rutstein RM, Meislich D, Brown T, Rudy BJ. Protease inhibitor therapy in HIV-infected children. AIDS Patient Care STDS. 2000;14:589-593
9. Flynn PM, Rudy BJ, Douglas SD, et al. Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy. J Infect Dis. 2004;190:271-279
10. Wiener L, Riekert K, Ryder C, Wood LV. Assessing medication adherence in adolescents with HIV when electronic monitoring is not feasible. AIDS Patient Care STDS. 2004;18:527-538
11. Abrams EJ, Weedon J, Bertolli J, et al. Aging cohort of perinatally human immunodeficiency virus-infected children in New York City. New York City Pediatric Surveillance of Disease Consortium. Pediatr Infect Dis J. 2001;20:511-517
12. de Martino M, Tovo PA, Balducci M, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA. 2000;284:190-197
13. Dolezal C, Mellins C, Brackis-Cott E, Abrams EJ. The reliability of reports of medical adherence from children with HIV and their adult caregivers. J Pediatr Psychol. 2003;28:355-361
14. Gortmaker SL, Hughes M, Cervia J, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med. 2001;345:1522-1528
15. McConnell MS, Byers RH, Frederick T, et al. Trends in antiretroviral therapy use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989-2001. J Acquir Immune Defic Syndr. 2005;38:488-494
16. Reddington C, Cohen J, Baldillo A, et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J. 2000;19:1148-1153
17. Belzer ME, Fuchs DN, Luftman GS, Tucker DJ. Antiretroviral adherence issues among HIV-positive adolescents and young adults. J Adolesc Health. 1999;25:316-319
18. Martinez J, Bell D, Camacho R, et al. Adherence to antiviral drug regimens in HIV-infected adolescent patients engaged in care in a comprehensive adolescent and young adult clinic [published correction appears in J Natl Med Assoc. 2000;92:294]. J Natl Med Assoc. 2000;92:55-61
19. Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M; Adolescent Medicine HIV/AIDS Research Network. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 2001;13:27-40
20. Steele RG, Grauer D. Adherence to antiretroviral therapy for pediatric HIV infection: review of the literature and recommendations for research. Clin Child Fam Psychol Rev. 2003;6:17-30
21. Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns. 2002;46:93-108
22. Ammassari A, Antinori A, Aloisi MS, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45:394-402
23. Havens J, Mellins CA, Hunter J. Psychiatric aspects of HIV/AIDS in childhood and adolescence. In: Taylor E, ed. Child and Adolescent Psychiatry: Modern Approaches. Malden, MA: Blackwell; 2002:828-841
24. Roberts KJ, Mann T. Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care. 2000;12:377-386
25. Joint United Nations Programme on HIV/AIDS. Pediatric HIV Infection and AIDS. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2004
26. Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41:285-297
27. Simoni J, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load: a metaanalytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(suppl 1):S23-S35
28. Elise A, France AM, Louise WM, et al. Assessment of adherence to highly active antiretroviral therapy in a cohort of African HIV-infected children in Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr. 2005;40:498-500
29. Van Dyke RB, Lee S, Johnson GM, et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics. 2002;109(4). Available at: www.pediatrics.org/cgi/content/full/109/4/e61
30. Temple ME, Koranyi KI, Nahata MC. The safety and antiviral effect of protease inhibitors in children. Pharmacotherapy. 2001;21:287-294
31. Byrne M, Honig J, Jurgrau A, Heffernan SM, Donahue MC. Achieving adherence with antiretroviral medications for pediatric HIV disease. AIDS Read. 2002;12:151-154, 161-164
32. Watson DC, Farley JJ. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. 1999;18:682-689
33. Katko E, Johnson GM, Fowler SL, Turner RB. Assessment of adherence with medications in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2001;20:1174-1176
34. Farley J, Hines S, Musk A, Ferrus S, Tepper V. Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr. 2003;33:211-218
35. van Rossum AM, Bergshoeff AS, Fraaij PL, et al. Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2002;21:743-747
36. Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23:1035-1041
37. Naar-King S, Frey M, Harris M, Arfken C. Measuring adherence to treatment of paediatric HIV/AIDS. AIDS Care. 2005;17:345-349
38. Steele RG, Anderson B, Rindel B, et al. Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. AIDS Care. 2001;13:617-629
39. Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med. 2005;159:764-770
40. Boni S, Pontali E, De Gol P, Pedemonte P, Bassetti D. Compliance to combination antiretroviral therapy in HIV-1 infected children. Int J Antimicrob Agents. 2000;16:371-372
41. Marhefka SL, Farley JJ, Rodrigue JR, Sandrik LL, Sleasman JW, Tepper VJ. Clinical assessment of medication adherence among HIV-infected children: examination of the Treatment Interview Protocol (TIP). AIDS Care. 2004;16:323-338
42. Moloney C, Damon B, Regan AM. Pediatric compliance in combination HIV therapy: getting it right the first time. Adv Nurse Pract. 1998;6(3):35-38
43. Pontali E. Facilitating adherence to highly active antiretroviral therapy in children with HIV infection: what are the issues and what can be done? Paediatr Drugs. 2005;7:137-149
44. Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J. 2003;22:56-62
45. Pugatch D, Bennett L, Patterson D. HIV medication adherence in adolescents: a qualitative study. J HIV/AIDS Prev Educ Adolesc Child. 2002;5:9-29
46. Battles HB, Wiener LS. From adolescence through young adulthood: psychosocial adjustment associated with long-term survival of HIV. J Adolesc Health. 2002;30:161-168
47. Giacomet V, Albano F, Starace F, et al. Adherence to antiretroviral therapy and its determinants in children with human immunodeficiency virus infection: a multicentre, national study. Acta Paediatr. 2003;92:1398-1402
48. Wrubel J, Moskowitz JT, Richards TA, Prakke H, Acree M, Folkman S. Pediatric adherence: perspectives of mothers of children with HIV. Soc Sci Med. 2005;61:2423-2433
49. Hammami N, Nostlinger C, Hoeree T, Lefevre P, Jonckheer T, Kolsteren P. Integrating adherence to highly active antiretroviral therapy into children's daily lives: a qualitative study. Pediatrics. 2004;114(5). Available at: www.pediatrics.org/cgi/content/full/114/5/e591
50. Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation- behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25:462-473
51. Berrien VM, Salazar JC, Reynolds E, McKay K. Adherence to antiretroviral therapy in HIV-infected pediatric patients improves with home-based intensive nursing intervention. AIDS Patient Care STDS. 2004;18:355-363
52. Gigliotti F, Murante BL, Weinberg GA. Short course directly observed therapy to monitor compliance with antiretroviral therapy in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2001;20:716-718
53. Roberts GM, Wheeler JG, Tucker NC, et al. Nonadherence with pediatric human immunodeficiency virus therapy as medical neglect. Pediatrics. 2004;114(3). Available at: www.pediatrics.org/cgi/content/full/114/3/e346
54. Lyon ME, Trexler C, Akpan-Townsend C, et al. A family group approach to increasing adherence to therapy in HIV-infected youths: results of a pilot project. AIDS Patient Care STDS. 2003;17:299-308
55. Shingadia D, Viani RM, Yogev R, et al. Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus. Pediatrics. 2000;105(6). Available at: www.pediatrics.org/cgi/content/full/105/6/e80
56. Rogers AS, Miller S, Murphy DA, Tanney M, Fortune T. The TREAT (Therapeutic Regimens Enhancing Adherence in Teens) program: theory and preliminary results. J Adolesc Health. 2001;29(3 suppl):30-38
57. Ellis DA, Naar-King S, Cunningham PB, Secord E. Use of multisystemic therapy to improve antiretroviral adherence and health outcomes in HIV-infected pediatric patients: evaluation of a pilot program. AIDS Patient Care STDS. 2006;20:112-121
58. Prochaska JO, Redding CA, Harlow LL, Rossi JS, Velicer WF. The transtheoretical model of change and HIV prevention: a review. Health Educ Q. 1994;21:471-486
59. New MJ, Earp MJ, Dominguez KL, et al. Pediatric IMPACT: An intervention to promote adherence to antiretroviral medications in pediatric HIV. Presented at: the National HIV Prevention Conference; June 12-15, 2005; Atlanta, GA
60. Koenig L, Chandwani S, Peralta L, Stein R, Barnes W. Adolescent IMPACT: conceptual basis for a developmentally-targeted intervention to minimize sexual transmission risk and promote adherence to treatment and care among adolescents living with HIV/AIDS. Presented at: the National HIV Prevention Conference; June 12-15, 2005; Atlanta, GA
61. Bosworth HB, Oddone EZ, Weinberger M. Patient Treatment Adherence: Concepts, Interventions, and Measurement. Mahwah, NJ: Lawrence Erlbaum; 2006
62. Meichenbaum D, Turk DC. Facilitating Treatment Adherence: A Practitioner's Guidebook. New York, NY: Plenum Press; 1987
63. Rapoff MA. Adherence to Pediatric Medical Regimens. New York, NY: Kluwer Academic/Plenum; 1999
64. Matsui D. Promoting adherence to medical treatment in chronic childhood illness: concepts, methods, and interventions. In: Drotar D, ed. Children's Adherence to Medication Treatment. Hillsdale, NJ: Lawrence Erlbaum; 2000:135-152
65. Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005;38:445-448
66. Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10:227-245
67. Bova CA, Fennie KP, Knafl GJ, Dieckhaus KD, Watrous E, Williams AB. Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS Behav. 2005;9:103-110
68. Brackis-Cott E, Mellins CA, Abrams E, Reval T, Dolezal C. Pediatric HIV medication adherence: the views of medical providers from two primary care programs. J Pediatr Health Care. 2003;17:252-260
69. Burger DM, van Rossum AM, Hugen PW, et al. Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children. Antimicrob Agents Chemother. 2001;45:701-705
70. Gatti G, Vigano A, Sala N, et al. Indinavir pharmacokinetics and parmacodynamics in children with human immunodeficiency virus infection. Antimicrob Agents Chemother. 2000;44:752-755
71. Pearson CR, Simoni JM, Hoff P, Kurth AE, Martin DP. Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behav. 2006; In press
72. DeRouen G, Jackson R. Can sensitivity to patient's culture encourage compliance? Fac Notes (New Orleans La). 1998;10:12-13
73. Dodds S, Blakley T, Lizzotte JM, et al. Retention, adherence, and compliance: special needs of HIV-infected adolescent girls and young women. J Adolesc Health. 2003;33(2 suppl):39-45
74. Pontali E, Feasi M, Toscanini F, et al. Adherence to combination antiretroviral treatment in children. HIV Clin Trials. 2001;2:466-473
75. Arora VK, Gupta R. Directly observed treatment for tuberculosis. Indian J Pediatr. 2003;70:885-889
76. Lemanek KL, Kamps J, Chung NB. Empirically supported treatments in pediatric psychology: regimen adherence. J Pediatr Psychol. 2001;26:253-275
77. Weaver KE, Llabre MM, Duran RE, et al. A stress and coping model of medication adherence and viral load in HIV-positive men and women on highly active antiretroviral therapy (HAART). Health Psychol. 2005;24:385-392
78. Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol. 2006;25:74-81
79. Starace F, Massa A, Amico KR, Fisher JD. Adherence to antiretroviral therapy: an empirical test of the information-motivation-behavioral skills model. Health Psychol. 2006;25:153-162
80. Johnson MO, Elliott TR, Neilands TB, Morin SF, Chesney MA. A social problem-solving model of adherence to HIV medications. Health Psychol. 2006;25:355-363
81. Kalichman SC, Cherry C, Cain D, et al. Internet-based health information consumer skills intervention for people living with HIV/AIDS. J Consult Clin Psychol. 2006;74:545-554
82. Wade SL, Carey J, Wolfe CR. An online family intervention to reduce parental distress following pediatric brain injury. J Consult Clin Psychol. 2006;74:445-454
83. Goode M, McMaugh A, Crisp J, Wales S, Ziegler JB. Adherence issues in children and adolescents receiving highly active antiretroviral therapy. AIDS Care. 2003;15:403-408
84. Hosek S, Harper GW, Domanico R. Predictors of medication adherence among HIV-infected youth. Psychol Health Med. 2005;10:166-179
85. Eley B, Nuttall J, Davies MA, et al. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents. S Afr Med J. 2004;94:643-646
86. Brundage RC, Yong FH, Fenton T, Spector SA, Starr SE, Fletcher CV. Intrapatient variability of efavirenz concentrations as a predictor of virologic response to antiretroviral therapy. Antimicrob Agents Chemother. 2004;48:979-984
87. Albano F, Spagnuolo MI, Berni Canani R, Guarino A. Adherence to antiretroviral therapy in HIV-infected children in Italy. AIDS Care. 1999;11:711-714